Shares of Zoetis (NYSE: ZTS) were falling today after the animal pharmaceutical company posted disappointing results in its third-quarter earnings report, missing the mark on both top and bottom lines, and lowered its guidance for the year.

The stock closed this Thursday afternoon down 11%.

Revenue in Q3 grew just 1%, or 5% in constant currency, to $2 billion, which was below estimates at $2.09 billion.

Continue reading

Source Fool.com